First-line all-oral NORCAP (vinorelbine/capecitabine) might be alternative to taxane-based chemotherapy for HER2-negative metastatic breast cancer

Kadri Altundag

doi:10.1007/s10549-016-4055-x

First-line all-oral NORCAP (vinorelbine/capecitabine) might be alternative to taxane-based chemotherapy for HER2-negative metastatic breast cancer

Kadri Altundag

Tria Residence

Araştırma sonucu: Dergiye katkı › Mektup › bilirkişi

Orijinal dil	İngilizce
Sayfa (başlangıç-bitiş)	385
Sayfa sayısı	1
Dergi	Breast Cancer Research and Treatment
Hacim	161
Basın numarası	2
DOI'lar	https://doi.org/10.1007/s10549-016-4055-x
Yayın durumu	Yayınlandı - 1 Oca 2017
Harici olarak yayınlandı	Evet

BM SKH

Bu sonuç, aşağıdaki Sürdürülebilir Kalkınma Hedefine/Hedeflerine katkıda bulunur

SKH 3 Sağlık ve Kaliteli Yaşam

Belgeye Erişim

10.1007/s10549-016-4055-x

Diger dosyalar ve linkler

Link to publication in Scopus

Bundan alıntı yap

@article{a76cfcf909214b3bb9502853edcdb618,

title = "First-line all-oral NORCAP (vinorelbine/capecitabine) might be alternative to taxane-based chemotherapy for HER2-negative metastatic breast cancer",

author = "Kadri Altundag",

year = "2017",

month = jan,

day = "1",

doi = "10.1007/s10549-016-4055-x",

language = "English",

volume = "161",

pages = "385",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - First-line all-oral NORCAP (vinorelbine/capecitabine) might be alternative to taxane-based chemotherapy for HER2-negative metastatic breast cancer

AU - Altundag, Kadri

PY - 2017/1/1

Y1 - 2017/1/1

UR - https://www.scopus.com/pages/publications/84995756422

U2 - 10.1007/s10549-016-4055-x

DO - 10.1007/s10549-016-4055-x

M3 - Letter

C2 - 27858315

AN - SCOPUS:84995756422

SN - 0167-6806

VL - 161

SP - 385

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 2

ER -